Are you hydrated?
Our Story
The Company
NDurance (Private) Limited is a Neutraceutical company based in Sri Lanka.
At NDurance, innovation is our lifeblood.
Starting with functional ingredients, we create innovative products that bring a unique, multi-sensory experience for the consumer.
We aim to provide functional and healthy products for those seeking to live life to the fullest, unlocking new opportunities in neutraceutical innovation.
The company was founded by Dr. Dilshan Balasuriya and Nishelli Perera (more commonly known as Bala and Bossman) in hope to one day put Sri Lanka on the map for neutraceutical innovation.
Dr. Dilshan Balasuriya
With a first class honours Pharmacology degree (BSc.) from University College London and a Ph.D. in Molecular Neuro Pharmacology from the University of Cambridge, Dr. Balasuriya has an exemplary academic record with 10 peer-reviewed scientific publications to date. He has studied the structure and function of proteins at the single-molecule level using atomic force microscopy (AFM). His research has led to a significant advancement in receptor biology.
Prior to this venture, he spearheaded new product development at a leading pharmaceutical company in Sri Lanka.
Dr. B is an avid adventurer, mountain climber, wild-life photographer and ornithologist.
Nishelli Perera
Nishelli Perera graduated from the University of North Texas with a bachelor's in Economics and a master's in Economic Research as the top graduate in her program.
She has 5 years’ work experience in the pharmaceutical industry through her position as Head of Strategy at Hemas Holdings; a leading pharmaceutical manufacturer and distributor in Sri Lanka.
Prior to this she spent eight years in Texas during which she was employed at a leading Analytics company. Her clients included Nestle, Walmart and global investment firms.
Nishelli is a certified fitness instructor and loves the out-doors.
Pulse: The Yeti Start-up Story
CosmoTV: Nishelli Perera 35 Under 35
Hatch + ReadMe: Entrepreneurship Stories
Our Purpose
In the News
